Virios Therapeutics Inc/$DWTX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Virios Therapeutics Inc
Dogwood Therapeutics Inc is a development-stage biopharmaceutical company focused on developing new medicines to treat pain and neuropathy. The pipeline is focused on treating chronic neuropathic pain and neuropathy. The Company operates in one segment and is a pre-revenue, development-stage biopharmaceutical company focused on developing new medicines to treat pain and peripheral neuropathy associated with cancer.
Ticker
$DWTX
Sector
Primary listing
Employees
8
Headquarters
Website
DWTX Metrics
BasicAdvanced
$48m
-
-$7.13
1.97
-
Price and volume
Market cap
$48m
Beta
1.97
52-week high
$9.50
52-week low
$1.28
Average daily volume
124k
Financial strength
Current ratio
2.756
Quick ratio
2.133
Long term debt to equity
0.141
Total debt to equity
0.217
Profitability
EBITDA (TTM)
-27.966
Effective tax rate (TTM)
-0.65%
Management effectiveness
Return on assets (TTM)
-18.95%
Return on equity (TTM)
-49.23%
Valuation
Price to book
0.57
Price to tangible book (TTM)
0.68
Price to free cash flow (TTM)
-0.456
Free cash flow yield (TTM)
-219.43%
Free cash flow per share (TTM)
-3.138
Growth
Earnings per share change (TTM)
-42.99%
3-year earnings per share growth (CAGR)
-36.34%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Virios Therapeutics Inc stock?
Virios Therapeutics Inc (DWTX) has a market cap of $48M as of May 01, 2026.
What is the P/E ratio for Virios Therapeutics Inc stock?
The price to earnings (P/E) ratio for Virios Therapeutics Inc (DWTX) stock is 0 as of May 01, 2026.
Does Virios Therapeutics Inc stock pay dividends?
No, Virios Therapeutics Inc (DWTX) stock does not pay dividends to its shareholders as of May 01, 2026.
When is the next Virios Therapeutics Inc dividend payment date?
Virios Therapeutics Inc (DWTX) stock does not pay dividends to its shareholders.
What is the beta indicator for Virios Therapeutics Inc?
Virios Therapeutics Inc (DWTX) has a beta rating of 1.97. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.